natgillin/translations-raw huggingface dataset:
These compounds act at the same receptor system as memantine, and therefore adverse reactions (mainly central nervous system (CNS)-related) may be more frequent or more pronounced (see also section 4.5). 
Te snovi delujejo na isti receptorski sistem kot memantin, zato so lahko neželeni učinki (zlasti s strani osrednjega živčnega sistema (OŽS) pogostejši in bolj izraženi (glejte tudi poglavje 4.5).
CARTON FOR 28 TABLETS - TREATMENT INITIATION PACK4 WEEK TREATMENT SCHEDULE 
ŠKATLA Z 28 TABLETAMI - PAKIRANJE ZA ZAČETEK ZDRAVLJENJA - ŠTIRI TEDENSKA SHEMA ZDRAVLJENJA
If you take a large overdose of Memantine Accord, contact your doctor or get medical advice, as you may need medical attention. 
V primeru, da ste zaužili prevelik odmerek zdravila Memantin Accord, obvestite svojega zdravnika ali se obrnite po nasvet na zdravstveno službo, ker boste morda potrebovali zdravniško obravnavo.
Not known Psychotic reactions2 
Psihotične reakcije2
The renal elimination rate of memantine under alkaline urine conditions may be reduced by a factor of 7-9 (see section 4.4). 
V primeru alkalnega urina lahko pride do zmanjšane hitrosti izločanja memantina za faktor 7 do 9 (glejte poglavje 4.4).
One tablet daily. 
Ena tableta na dan.
Studies in volunteers have demonstrated linear pharmacokinetics in the dose range of 10-40 mg. 
Študije na zdravih prostovoljcih so pokazale, da ima memantin linearno farmakokinetiko v razponu odmerkov od 10 do 40 mg.
The Memantine Accord treatment initiation pack is only to be used for the beginning of the treatment with Memantine Accord. 
Začetni paket za zdravljenje z zdravilom Memantin Accord se uporablja samo za začetek zdravljenja z zdravilom Memantin Accord.
In the most extreme case of overdose, the patient survived the oral intake of a total of 2,000 mg memantine with effects on the central nervous system (coma for 10 days, and later diplopia and agitation). 
V najekstremnejšem primeru prevelikega odmerjanja je bolnik preživel peroralni vnos 2000 mg memantina z učinki na centralni živčni sistem (desetdnevna koma, kasneje diplopija in vznemirjenost).
Date of first authorisation: 04 December 2013 
Datum prve pridobitve dovoljenja: 04-12-2013
Date of first authorisation: 04 December 2013 Date of latest renewal: 3rd August 2018 
Datum prve pridobitve dovoljenja: 04-12-2013 Datum zadnjega podaljšanja: 3. avgusta 2018
'Possible side effects'. 
»Možni neželeni učinki«.
If you go into hospital, let your doctor know that you are taking Memantine Accord. 
V primeru, da ste sprejeti v bolnišnico, obvestite zdravnika, da jemljete zdravilo Memantin Accord.
The recommended treatment dose of 20 mg per day is achieved by a gradual increase of the Memantine Accord dose during the first 3 weeks of treatment. 
Priporočeni zdravilni odmerek 20 mg na dan se doseže s postopnim povečevanjem odmerka zdravila Memantin Accord med prvimi tremi tedni zdravljenja.
Do not take Memantine Accord: 
Ne jemljite zdravila Memantin Accord:
If you find you have forgotten to take your dose of Memantine Accord, wait and take your next dose at the usual time. 
Če ste ugotovili, da ste pozabili vzeti predpisani odmerek zdravila Memantin Accord, počakajte in vzemite naslednji odmerek ob običajnem času.
What Memantine Accord is and what it is used for 2. 
Kaj je zdravilo Memantin Accord in za kaj ga uporabljamo 2.
Memantine Accord with food and drink 
Zdravilo Memantin Accord skupaj s hrano in pijačo
Very Rare (may affect up to 1 in 10,000 people): 
Zelo redki (prizadanejo lahko do 1 od 10.000 oseb):
if you are allergic to memantine hydrochloride or any of the other ingredients of this medicine (listed in section 6). 
če ste alergični na memantinijev klorid ali katero koli sestavino tega zdravila (glejte poglavje 6).
Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactosemalabsorption should not take this medicinal product. 
Bolniki z redko dedno intoleranco za galaktozo, laponsko obliko zmanjšane aktivnosti laktaze ali malabsorpcijo glukoze/galaktoze, ne smejo jemati tega zdravila.
If you forget to take Memantine Accord 
Če ste pozabili vzeti zdravilo Memantin Accord
If you forget to take Memantine Accord If you find you have forgotten to take your dose of Memantine Accord, wait and take your next dose at the usual time. 
Če ste pozabili vzeti zdravilo Memantin Accord Če ste ugotovili, da ste pozabili vzeti predpisani odmerek zdravila Memantin Accord, počakajte in vzemite naslednji odmerek ob običajnem času.
PVC/PE/PVDC-aluminium blister. 
PVC/PE/PVDC-aluminijev pretisni omot.
Furthermore, memantine has minor to moderate influence on the ability to drive and use machines such that outpatients should be warned to take special care. 
Prav tako ima memantin majhen do zmerno velik vpliv na sposobnost vožnje in upravljanja s stroji, zato je potrebno bolnike opozoriti na posebno previdnost.
When daily doses of 5-30 mg were administered, a mean cerebrospinal fluid (CSF)/serum ratio of 0.52 was calculated. 
Ob dnevnih odmerkih 5 do 30 mg so izračunali razmerje cerebrospinalni likvor (CSL)/serum 0,52.
amantadine, ketamine, dextromethorphan dantrolene, baclofen cimetidine, ranitidine, procainamide, quinidine, quinine, nicotine hydrochlorothiazide (or any combination with hydrochlorothiazide) anticholinergics (substances generally used to treat movement disorders or intestinal cramps) anticonvulsants (substances used to prevent and relieve seizures) barbiturates (substances generally used to induce sleep) dopaminergic agonists (substances such as L-dopa, bromocriptine) neuroleptics (substances used in the treatment of mental disorders) oral anticoagulants 
amantadin, ketamin, dekstrometorfan dantrolen, baklofen cimetidin, ranitidin, prokainamid, kinidin, kinin, nikotin hidroklorotiazid (ali kombinacije zdravil, ki vsebujejo hidroklorotiazid) antiholinergiki (zdravila, ki se na splošno uporabljajo za zdravljenje motenj gibanja in trebušnih krčev) antikonvulzivi (zdravila za preprečevanje ali lajšanje epileptičnih krčev) barbiturati (zdravila, ki se na splošno uporabljajo kot uspavala) dopaminergični agonisti (učinkovine kot L-dopa, bromokriptin) nevroleptiki (zdravila za zdravljenje duševnih motenj) peroralni antikoagulanti
If you have been told by your doctor that you have an intolerance to some sugars, please contact your doctor before taking this medicinal product. 
Če vam je zdravnik povedal, da ne prenašate nekaterih sladkorjev, se pred jemanjem zdravila posvetujte s svojim zdravnikom.
At the beginning of treatment you will start by using Memantine Accord 5 mg film-coated ablets once a day. 
Na začetku boste zdravljenje začeli z jemanjem zdravila Memantin Accord 5 mg filmsko obložene tablete enkrat dnevno.
From the fourth week on, the usual dose is 2tablets once a day (1 x 20 mg). 
Od četrtega tedna naprej je običajni odmerek 2 tableti enkrat dnevno (1 x 20 mg).
Additional for 15 mg and 20 mg film-coated tablets Iron oxide yellow and red (E 172) 
Dodatno za 15 mg in 20 mg filmsko obložene tablete rumeni in rdeči železov oksid (E 172)
In particular, Memantine Accord may change the effects of the following medicines and their dose may need to be adjusted by your doctor: 
Posebno v primeru, da skupaj z zdravilom Memantin Accord jemljete naslednja zdravila, se učinki le teh lahko spremenijo in bo morda vaš zdravnik moral prilagoditi odmerek:
PVC/PE/PVDC-aluminium blister 
PVC/PE/PVDC-aluminijev pretisni omot
• Headache, sleepiness, constipation, elevated liver function test, dizziness, balance disorders, shortness of breath, high blood pressure and drug hypersensitivity 
• glavobol, zaspanost, zaprtje, zvišani jetrni funkcijski testi, omotica, motnje ravnotežja, zasoplost, visok krvni tlak in preobčutljivost za zdravilo
At a dose of memantine of 20 mg per day the CSF levels match the ki-value (ki = inhibition constant) of memantine, which is 0.5 μmol in human frontal cortex. 
Pri odmerku 20 mg memantina na dan so vrednosti v likvorju skladne s ki vrednostjo (ki = konstanta inhibicije) memantina, ki je 0,5 µmol v frontalnem korteksu pri človeku.
When patients were identified with concurrent worsening in all three domains, results showed a statistically significant effect of memantine in preventing worsening, as twice as many placebo-treated 7 patients as memantine-treated patients showed worsening in all three domains (21 % vs. 11 %, p < 0.0001). 
Pri bolnikih, kjer so ocenili hkratno poslabšanje vseh treh domen, so rezultati pokazali statistično značilen učinek memantina pri preprečevanju poslabšanja, saj se je pri dvakrat več bolnikih, ki so prejemali placebo, kot pri bolnikih, zdravljenih z memantinom, pokazalo poslabšanje na področju vseh treh domen (21 % proti 11 %, p < 0,0001).
In the overdose cases below 140 mg or unknown dose the patients revealed symptoms from central nervous system (confusion, drowsiness, somnolence, vertigo, agitation, aggression, hallucination, and gait disturbance) and/or of gastrointestinal origin (vomiting and diarrhoea). 
Pri prekomernem odmerjanju do 140 mg ali pri neznanih odmerkih so se pri bolnikih pokazali simptomi povezani s centralnim živčnim sistemom (zmedenost, dremavost, zaspanost, vrtoglavica, vznemirjenost, agresivnosti, halucinacije in motnje hoje) in/ali prebavili (bruhanje in driska).
What you need to know before you take Memantine Accord 3. 
Kaj morate vedeti, preden boste vzeli zdravilo Memantin Accord 3.
In postmarketing experience these events have been reported in patients treated with memantine. 
V okviru postmarketinških izkušenj so te dogodke navajali pri bolnikih, zdravljenih z memantinom.
• Tiredness, fungal infections, confusion, hallucinations, vomiting, abnormal gait, heart failure and venous blood clotting (thrombosis/thromboembolism). 
• utrujenost, glivična okužba, zmedenost, halucinacije, bruhanje, neobičajna hoja, odpoved srca in krvni strdki v venah (tromboza/tromboembolija)
The tablet can be divided into equal doses. 
Tableto je mogoče razdeliti na dva enaka odmerka.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist. 
Če imate kakršna koli vprašanja o uporabi tega zdravila, se obrnite na svojega zdravnika ali farmacevta.
Lactose monohydrate Microcrystalline cellulose Silica, colloidal anhydrous Crospovidone Magnesium stearate 
Jedro tablete laktoza monohidrat mikrokristalna celuloza brezvodni koloidni silicijev dioksid krospovidon magnezijev stearat
The usual starting dose is half a tablet once a day (1 x 5 mg) for the first week. 
Običajni začetni odmerek je polovica tablete enkrat dnevno (1 x 5 mg) v prvem tednu.
What you need to know before you take Memantine Accord 
Kaj morate vedeti, preden boste vzeli zdravilo Memantin Accord
Continue to take Memantine Accord as long as it is of benefit to you. 
Jemljite zdravilo Memantin Accord tako dolgo, kot vam pomaga.
• Inflammation of the pancreas, inflammation of the liver and psychotic reactions 
• vnetje trebušne slinavke, vnetje jeter in psihotične reakcije
Talk to your doctor or pharmacist before taking Memantine Accord if you have a history of epileptic seizures if you have recently experienced a myocardial infarction (heart attack), or if you are suffering rom congestive heart failure or from an uncontrolled hypertension (high blood pressure). 
Pogovorite se z zdravnikom ali s farmacevtom, preden boste vzeli zdravilo Memantin Accord: če ste v preteklosti imeli epileptične napade, če ste pred kratkim preboleli srčni infarkt (srčna kap), imate kongestivno srčno odpoved ali neurejeno hipertenzijo (visok krvni tlak).
Memantine Accord belongs to a group of medicines known as anti-dementia medicines. 
Zdravilo Memantin Accord sodi v skupino zdravil, znanih kot zdravila za zdravljenje demence.
Uncommon Confusion Uncommon Hallucinations1 
Zaspanost Zmedenost Halucinacije1
Memantine Accordis used for the treatment of patients with moderate to severe Alzheimer's disease. 
Zdravilo Memantin Accord uporabljamo za zdravljenje bolnikov z zmerno do hudo Alzheimerjevo boleznijo.
• Inflammation of the pancreas, inflammation of the liver and psychotic reactions Alzheimer's disease has been associated with depression, suicidal ideation and suicide. 
• vnetje trebušne slinavke, vnetje jeter in psihotične reakcije Obstaja povezava med Alzheimerjevo boleznijo in depresijo, samomorilnimi mislimi in samomorom.
Other medicines and Memantine Accord 
Druga zdravila in zdravilo Memantin Accord
In single-dose pharmacokinetic (PK) studies in young healthy subjects, no relevant active substanceactive substance interaction of memantine with glyburide/metformin or donepezil was observed. 
V raziskavah farmakokinetike (PK) posameznega odmerka pri mladih zdravih osebah ni bilo opaziti součinkovanja memantina z gliburidom/metforminom ali donepezilom.
The tablets can be divided into equal doses. 
Tablete se lahko deli na enake odmerke.
Pack sizes of 14, 28, 30, 42, 50, 56, 98, 100 and 112 tablets are presented. 
V škatli je po 14, 28, 30, 42, 50, 56, 98, 100 in 112 tablet.
In general, taking too much Memantine Accord should not result in any harm to you. 
Na splošno zaužitje večjega odmerka zdravila Memantin Accord ne sme imeti škodljivih posledic.
Common (may affect up to 1 in 10 people): 
Pogosti (prizadanejo lahko do 1 od 10 oseb):
Main human metabolites are N-3,5-dimethyl-gludantan, the isomeric mixture of 4-and 6-hydroxymemantine, and 1-nitroso-3,5-dimethyl-adamantane. 
Pri človeku so poglavitni metaboliti N3,5-dimetil-gludantan, izomerna mešanica 4- in 6-hidroksi-memantina in 1-nitrozo-3,5-dimetiladamantana.
This is increased to one tablet once a day (1 x 10 mg) in the second week and to 1 and a half tablet once a day (1 x 15 mg) in the third week. 
V drugem tednu povišamo odmerek na eno tableto enkrat dnevno (1 x 10 mg) in v tretjem tednu na 1 in ½ tablete enkrat dnevno (1 x 15 mg).
What Memantine Accord is and what it is used for 
Kaj je zdravilo Memantin Accord in za kaj ga uporabljamo
Do not use Memantine Accord after the expiry date which is stated on the carton and the blister after EXP. 
Zdravila Memantin Accord ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in na pretisnem omotu poleg oznake EXP. Rok uporabnosti se izteče na zadnji dan navedenega meseca.
Standard clinical procedures to remove active substance material, e.g. gastric lavage, carbomedicinalis (interruption of potential entero-hepatic recirculation), acidification of urine, forced diuresis should be used as appropriate. 
Pri odstranjevanju zdravilne učinkovine uporabljamo ustrezne standardne klinične postopke, kot so izpiranje želodca, medicinsko oglje (preprečevanje možne enterohepatične recirkulacije), acidifikacija urina, prisilna diureza.
Memantine-treated patients showed a statistically significantly better effect than placebo-treated patients on the primary endpoints: Alzheimer´s disease assessment scale (ADAS-cog) (p = 0.003) and CIBIC-plus (p = 0.004) at week 24 last observation carried forward (LOCF). 
Pri bolnikih, zdravljenih z memantinom, se je pokazal statistično značilno boljši učinek kot pri bolnikih, ki so prejemali placebo pri primarnih ciljih študije: lestvica ocene Alzheimerjeve bolezni (ADAS-cog) (p = 0,003) in CIBIC-plus (p = 0,004) po 24 tednih prenosa zadnjih opaženih rezultatov naprej (LOCF).
Memantine Accord film-coated tablets are available in blister packs (PVC/PE/PVDC-aluminium blister) of 14 tablets, 28 tablets, 30 tablets, 42 tablets, 50 tablets, 56 tablets, 98 tablets, 100 tablets and 112 tablets. 
Memantin Accord filmsko obložene tablete se nahajajo v pretisnih omotih (PVC/PE/PVDC-aluminijev pretisni omot) v škatlah z 14 tabletami, 28 tabletami, 30 tabletami, 42 tabletami, 50 tabletami, 56 tabletami, 98 tabletami, 100 tabletami in 112 tabletami.
Memantine Accord film-coated tablets are available in blister packs (PVC/PE/PVDC-aluminium blister) of 14 tablets, 28 tablets, 42 tablets, 56 tablets and 98 tablets. 
Memantin Accord filmsko obložene tablete se nahajajo v pretisnih omotih (PVC/PE/PVDC-aluminijev pretisni omot) v škatlah z 14 tabletami, 28 tabletami, 42 tabletami, 56 tabletami in 98 tabletami.
How to take Memantine Accord 4. 
Kako jemati zdravilo Memantin Accord 4.
Uncommon (may affect up to 1 in 100 people): 
Občasni (prizadanejo lahko do 1 od 100 oseb):
If you take more Memantine Accord than you should 
Če ste vzeli večji odmerek zdravila Memantin Accord, kot bi smeli
The following adverse reactions listed in the table below have been accumulated in clinical studies with memantine and since its introduction in the market. 
V spodnji preglednici so navedeni podatki o neželenih učinkih zdravila, zbrani v kliničnih študijah memantina in od začetka trženja dalje.
Blister packs containing 28 tablets with 7 tablets of 5 mg, 7 tablets of 10 mg, 7 tablets of 15 mg and 7 tablets of 20 mg. 
Pretisni omoti po 28 tablet s sedmimi tabletami po 5 mg, sedmimi tabletami po 10 mg, sedmimi po 15 mg in sedmimi tabletami po 20 mg.
Pack sizes of 14, 28, 42, 56 and 98 tablets are presented. 
Na voljo so pakiranja z 14, 28, 42, 56 in 98 tabletami.
memantine hydrochloride 
memantinijev klorid
Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu. 
Podrobni podatki o tem izdelku so na voljo na spletni strani Evropske agencije za zdravila http://www.ema.europa.eu.
Medicinal products subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2). 
POGOJI ALI OMEJITVE GLEDE OSKRBE IN UPORABE Predpisovanje in izdaja zdravila je le s posebnim režimom (glejte Prilogo I: Povzetek glavnih značilnosti zdravila, poglavje 4.2).
Administration of Memantine Accord is not recommended in patients with severe hepatic impairment. 
Dajanje zdravila Memantin Accord ni priporočeno bolnikom s hudo jetrno okvaro.
A pivotal monotherapy study of memantine in the treatment of mild to moderate Alzheimer's disease (MMSE total scores at baseline of 10-22) included 403 patients. 
Temeljna študija memantina v monoterapiji pri zdravljenju bolnikov z blago do zmerno Alzheimerjevo boleznijo (skupna ocena ob vključitvi 10 do 22 točk na KPSS) je zajela 403 bolnike.
What Memantine Accord looks like and contents of the pack 
Izgled zdravila Memantin Accord in vsebina pakiranja
15 mg tablet week 4 and beyond 20 mg tablets once a day Maintenance dose 
4. teden in naprej 20 mg tableta enkrat dnevno Vzdrževalni odmerek
The recommended dose of Memantine Accord for adults and older people is 20 mg once a day. 
Za odrasle in starejše je priporočeni odmerek zdravila Memantin Accord 20 mg enkrat dnevno.
Daily doses of 20 mg lead to steady-state plasma concentrations of memantine ranging from 70-150 ng/ml (0.5-1μmol) with large interindividual variations. 
Ob dnevnih odmerkih 20 mg so v stanju dinamičnega ravnovesja dosežene plazemske koncentracije memantina v razponu od 70 do 150 ng/ml (0,5 - 1 µmol) ob veliki variabilnosti med posamezniki.
The use of medicinal products called amantadine (for the treatment of Parkinson´s disease), ketamine (a substance generally used as an anaesthetic), dextromethorphan (generally used to treat cough) and other NMDA-antagonists at the same time should be avoided. 
Potrebno se je izogibati sočasni uporabi zdravil, kot so amantadin (za zdravljenje Parkinsonove bolezni), ketamin (snov, ki se uprablja kot anestetik), dekstrometorfan (splošna uporaba pri zdravljenju kašlja) in ostali zaviralci receptorjev NMDA.
Memantine Accord is not recommended for use in children below 18 years due to a lack of data on safety and efficacy. 
Zaradi pomanjkanja podatkov o varnosti in učinkovitosti uporaba zdravila Memantin Accord pri otrocih pod 18 let ni priporočljiva.
Memantine Accord contains lactose 
Zdravilo Memantin Accord vsebuje laktozo
Memantine Accord contains lactose. 
Zdravilo Memantin Accord vsebuje laktozo.
In these situations the treatment should be carefully supervised, and the clinical benefit of Memantine Accord assessed by your doctor on a regular basis. 
Vaš zdravnik naj redno ocenjuje klinično korist zdravila Memantin Accord.
Film-coated tablets 14 x 1 film-coated tablets 28 x 1 film-coated tablets 56 x 1 film-coated tablets 98 x 1 film-coated tablets 
filmsko obložene tablete 14 x 1 filmsko obložena tableta 28 x 1 filmsko obložena tableta 56 x 1 filmsko obložena tableta 98 x 1 filmsko obložena tableta
Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu. 
Podrobni podatki o tem zdravilu so na voljo na spletni strani Evropske agencije za zdravila http://www.ema.europa.eu.
Hypertension Uncommon Venous thrombosis/thromboembolism 
Venska tromboza/tromboembolija
The patient should take two 10 mg film-coated tablets (20 mg) per day. 
Bolnik naj jemlje dve 10 mg filmsko obloženi tableti (20 mg) na dan. Vzdrževalni odmerek
Women taking Memantine Accord should not breast-feed. 
Ženske, ki jemljejo zdravilo Memantin Accord, ne smejo dojiti.
One treatment initiation pack contains 28 tablets in 4 blisters with 7 tablets of Memantine Accord 5 mg, 7 tablets of Memantine Accord 10 mg, 7 tablets of Memantine Accord 15 mg and 7 tablets of Memantine Accord 20 mg. 
Eno pakiranje za začetno zdravljenje vsebuje 28 tablet v štirih pretisnih omotih s sedmimi tabletami zdravila Memantin Accord 5 mg, s sedmimi tabletami zdravila Memantin Accord 10 mg, s sedmimi tabletami zdravila Memantin Accord 15 mg in sedmimi tabletami zdravila Memantin Accord 20 mg.
Memantine Accord 5 mg, 10 mg, 15 mg; 20 mg film-coated tablets 
Memantin Accord 5 mg, 10 mg, 15 mg, 20 mg
INNER CARTON FOR BLISTER PACK 
NOTRANJA ŠKATLA ZA PRETISNI OMOT
On the basis of the clinical studies, the recommended dose for patients over the age of 65 years is 20 mg per day (two 10 mg tablets once a day) as described above. 
Na podlagi kliničnih študij je priporočen odmerek za bolnike nad 65 let starosti 20 mg na dan (dve 10 mg tableti enkrat dnevno), kot je opisano zgoraj.
Memantine Accord should be administered orally once a day. 
Zdravilo Memantin Accord jemljite peroralno enkrat dnevno.
On the basis of the clinical studies, the recommended dose for patients over the age of 65 years is 20 mg per day (20 mg tablets once a day) as described above. 
Na podlagi kliničnih študij je priporočen odmerek za bolnike nad 65 let starosti 20 mg na dan (20 mg tablete enkrat dnevno), kot je opisano zgoraj.
Balance disorders Uncommon Gait abnormal Very rare 
Omotica motnje ravnotežja Neobičajna hoja Epileptični napadi
Uncommon Vomiting Not known Pancreatitis2 
Zaprtje Bruhanje Pankreatitis2
You should inform your doctor if you have recently changed or intend to change your diet substantially (e.g. from normal diet to strict vegetarian diet) or if you are suffering from states of renal tubulary acidosis (RTA, an excess of acid-forming substances in the blood due to renal dysfunction (poor kidney function)) or severe infections of the urinary tract (structure that carries urine), as your doctor may need to adjust the dose of your medicine. 
Obvestite svojega zdravnika, če ste pred kratkim spremenili ali če nameravate bistveno spremeniti prehrano (npr. če preidete iz običajne hrane na strogo vegetarijansko prehrano), ali če imate ledvično tubularno acidozo (preveliko količino kislih spojin v krvi zaradi renalne disfunkcije (slabo delovanje ledvic)) ali če ste zboleli zaradi hudega vnetja sečil (strukture po kateri se prenaša seč).
EU/1/13/880/013 28 film-coated tablets 
EU/1/1/3/880/013 28 filmsko obloženih tablet
Uncommon Fungal infections 
Glivična okužba
From Week 4 on: 
Od 4. tedna dalje
Hypromellose 
Hipertenzija
In a study using orally administered 14C-memantine, a mean of 84 % of the dose was recovered within 
V študiji peroralnega 14C-memantina se je izločilo 84 % odmerka v 20 dneh, več kot 99 % preko ledvic.
Your doctor will tell you whether your illness allows you to drive and to use machines safely.Also, Memantine Accord may change your reactivity, making driving or operating machinery inappropriate. 
Vpliv na sposobnost upravljanja vozil in strojev Vaš zdravnik vam bo povedal, če zaradi vaše bolezni lahko varno vozite in varno upravljate s stroji.
How to store Memantine Accord 6. 
Shranjevanje zdravila Memantin Accord 6.
Maintenance dose 
Prilagajanje odmerka
7 x Memantine Accord 15 mg 
7 x Memantin Accord 15 mg